Focused on building reliable datasets, financial models, and research tools for value-minded investors. Committed to turning complex data into practical guidance for value-investing and long-term wealth.
Dr. Charlie Tian is the founder and CEO of GuruFocus.com, a leading global investment research platform established in 2004. With a Ph.D. in physics, Dr. Tian transitioned from science to finance, applying a data-driven, disciplined approach to value investing.
MedlineMDLN 16 Earnings per Share (Diluted) is $0.40 as of Jun. 2026. GuruFocus rates MDLN with a GF Score™ of 16/100. The stock has 4 warning signs investors should review. Among 662 Medical Devices & Instruments companies, Medline ranks worse than 151057.25% on this metric.
Medline's EPS (Basic) for the
three
months ended in Jun. 2026 was $0.07.
Its EPS (Basic) for the trailing twelve months (TTM) ended in Jun. 2026 was $0.40.
Medline's EPS without NRI for the
three
months ended in Jun. 2026 was $0.50.
Its EPS without NRI for the trailing twelve months (TTM) ended in Jun. 2026 was $1.00.
During the past 12 months, Medline's average EPS without NRIGrowth Rate was -1.00% per year.
Medline (NAS:MDLN) Earnings per Share (Diluted) Explanation
Earnings Per Share (EPS) is the single most important variable used by Wall Street in determining the earnings power of a company. But investors need to be aware that Earnings per Share can be easily manipulated by adjusting depreciation and amortization rate or non-recurring items. That's why GuruFocus lists EPS without NRI, which better reflects the company's underlying performance.
Be Aware
Compared with Earnings per share, a company's cash flow is better indicator of the company's earnings power.
If a company's earnings per share is less than cash flow per share over long term, investors need to be cautious and find out why.
Medline Earnings per Share (Diluted) Related Terms
Medline Earnings per Share (Diluted) Historical Data
* Premium members only.
The historical data trend for Medline's Earnings per Share (Diluted) can be seen below:
* For Operating Data section: All numbers are indicated by the unit behind each term and all currency related amount are in USD. * For other sections: All numbers are in millions except for per share data, ratio, and percentage. All currency related amount are indicated in the company's associated stock exchange currency.
MDLN vs RMD, WST, SOLV: Earnings per Share (Diluted) Comparison
For the Medical Instruments & Supplies subindustry, Medline's PE Ratio, along with its competitors' market caps and PE Ratio data, can be viewed below:
* Competitive companies are chosen from companies within the same industry, with headquarter located in same country, with closest market capitalization; x-axis shows the market cap, and y-axis shows the term value; the bigger the dot, the larger the market cap. Note that "N/A" values will not show up in the chart.
Medline PE Ratio vs Medical Devices & Instruments Industry
For the Medical Devices & Instruments industry and Healthcare sector, Medline's PE Ratio distribution charts can be found below:
* The bar in red indicates where Medline's PE Ratio falls into.
Earnings Per Share (EPS) is the amount of earnings per outstanding share of the company's stock. In calculating earnings per share, the dividends of preferred stocks need to subtracted from the total net income first.
Medline's Earnings Per Share (Diluted) for the fiscal year that ended in Dec. 2025 is calculated as
Earnings per Share (Diluted) for the trailing twelve months (TTM) ended in Jun. 2026 adds up the quarterly data reported by the company within the most recent 12 months, which was $0.40
* For Operating Data section: All numbers are indicated by the unit behind each term and all currency related amount are in USD. * For other sections: All numbers are in millions except for per share data, ratio, and percentage. All currency related amount are indicated in the company's associated stock exchange currency.
Companies also reported diluted shares in their financial reports. Diluted shares include the shares of convertibles or warrants outstanding.
What does a Earnings per Share (Diluted) of $0.40 mean?
Medline (MDLN) has a Earnings per Share (Diluted) of $0.40 as of Jun. 2026. Diluted EPS equals net earnings divided by average shares outstanding, including dilutive securities. View historical data on Medline and its competitors. According to the industry distribution chart, Medline ranks #999999 out of 662 companies in the Medical Devices & Instruments industry.
Is Medline's Earnings per Share (Diluted) too high?
Medline's current Earnings per Share (Diluted) is $0.40. The Medical Devices & Instruments industry median Earnings per Share (Diluted) is 7.75. Medline's value of $0.40 is 94.8% below this industry median. Based on the distribution chart, Medline ranks #999999 out of 662 companies in the Medical Devices & Instruments industry, which is in the bottom quartile relative to peers. Overall, Medline has a GF Score™ of 16/100, reflecting its overall financial health beyond just this single metric.
How does Medline's Earnings per Share (Diluted) compare to RMD and WST?
According to the Medical Devices & Instruments industry distribution chart, Medline ranks #999999 out of 662 companies for Earnings per Share (Diluted). This places Medline in the lower half of its industry. The industry median Earnings per Share (Diluted) is 7.75. Medline's value of $0.40 is 94.8% below this benchmark. See the competitive comparison table and distribution chart on this page for a detailed peer-by-peer breakdown.
What is a good Earnings per Share (Diluted) for a Medical Devices & Instruments company?
The median Earnings per Share (Diluted) among Medical Devices & Instruments companies is 7.75, based on 662 companies in the industry. Companies in the top quartile (top 25%) have a Earnings per Share (Diluted) significantly above this median, while those in the bottom quartile fall well below. However, Earnings per Share (Diluted) should not be evaluated in isolation — investors should consider it alongside profitability, growth, and financial strength metrics. Medline's current Earnings per Share (Diluted) of $0.40 is 94.8% below the industry median. Use the industry distribution chart on this page to see where any company falls relative to its peers.
What does a high Earnings per Share (Diluted) mean?
A high Earnings per Share (Diluted) can signal that a stock is expensive relative to its fundamentals. Diluted EPS equals net earnings divided by average shares outstanding, including dilutive securities. View historical data on Medline and its competitors. For the Medical Devices & Instruments industry, the median Earnings per Share (Diluted) is 7.75 — values significantly above this may indicate overvaluation, while values below may suggest a bargain or underlying issues. Medline's current Earnings per Share (Diluted) is $0.40. However, context matters — high-growth companies often justify higher valuations. Always evaluate alongside other metrics like GF Score™ and GF Value™.
Is Medline stock overvalued right now?
Medline (MDLN) has a current Earnings per Share (Diluted) of $0.40. The current Earnings per Share (Diluted) is $0.40 and 94.8% below the Medical Devices & Instruments industry median of 7.75. Medline's overall GF Score™ is 16/100 with 4 warning signs to review. Investors should evaluate multiple metrics — including profitability, growth, and financial strength — before making a decision.
How is Earnings per Share (Diluted) calculated?
Earnings per Share (Diluted) is calculated from a company's financial statements. For Medline (MDLN), the current Earnings per Share (Diluted) is $0.40 as of Jun. 2026. GuruFocus calculates this using data sourced from SEC filings and annual reports. See the calculation section and 30-year financial data on this page for the full breakdown.
Medline is the largest provider of medical-surgical products and supply chain solutions in the US. The company generates over 90% of its revenue domestically and serves some of the largest US health systems. Medline offers approximately 190,000 Medline-branded products across more than 250 product families—including front-line care, surgical solutions, and laboratory and diagnostics—as well as roughly 150,000 third-party products sourced from over 1,250 vendors. The company maintains prime vendor relationships with many customers, acting as the primary consolidated logistics partner for their medical-surgical needs. Medline has significant scale, supported by more than 30 manufacturing facilities and a fleet of over 2,000 owned delivery trucks. Medline went public in December 2025.
16GF Score
Get the complete analysis for MDLN
Earnings per Share (Diluted) is just one metric. See GF Value™, 30-year financials, guru trades, warning signs, and more.
Quick Browse
Personalize
Premium Gurus 
Create New Portfolio
MDLN has been successfully added to your 
